EQ Stock Analysis: Buy, Sell, or Hold?
EQ - Equillium, Inc. Common Stock
$2.06
0.01 (0.49%)
▲
5d:
-11.59%
30d:
+17.71%
90d:
+47.14%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When EQ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: EQ is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: EQ is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: EQ is currently trading at $2.06, which is considered fair relative to its 30-day fair value range of $1.86 to $2.13.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $1.82, while resistance sits at $2.49.
Market Sentiment: EQ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.38 (+211.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $1.82, while resistance sits at $2.49.
Market Sentiment: EQ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.38 (+211.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.86 -
$2.13
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 211.0% below Wall St target ($6.38)
- WARNING: Recommendation downgraded due to -11.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.86 -
$2.13
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.82
Resistance Level
$2.49
Current Trend
Strong Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.20
Wall Street Target
$6.38
(+211.0%)
Revenue Growth (YoY)
-52.3%
Share & Embed Analysis
Last updated: April 29, 2026 1:34 PM ET
Data refreshes hourly during market hours. Next update: 2:34 PM
Data refreshes hourly during market hours. Next update: 2:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EQ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Christine Zedelmayer
SELL
120312 shares
2026-03-13
Christine Zedelmayer
SELL
181219 shares
2026-03-09
Christine Zedelmayer
SELL
185937 shares
2026-02-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 50 HOLD |